Randomized Phase II Study for Evaluation of Efficacy and Safety of Maintenance Treatment With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction Treatment With mFOLFOX6 Plus Panitumumab and Re-induction With mFOLFOX6 Plus Panitumumab in Case of Progression for First-line Treatment of Patients With Metastatic Colorectal Cancer
Phase of Trial: Phase II
Latest Information Update: 06 Jul 2019
Price : $35 *
At a glance
- Drugs Panitumumab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Carcinoma; Colorectal cancer
- Focus Therapeutic Use
- Acronyms PanaMa
- 05 Mar 2019 Planned End Date changed from 1 Jun 2018 to 1 Jun 2020.
- 05 Mar 2019 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2019.
- 11 Oct 2016 Trial design presented at 41st European Society for Medical Oncology Congress.